The development of triple g, whose approval could coincide closely with approval of Mounjaro for obesity, will add to an ever-growing arsenal against the plague of obesity, which affects nearly 40 percent of American adults
While it varies by medication and insurance plan, Klinic facilitates the process directly with insurers to simplify coverage issues
Clinical trials have demonstrated substantial reductions in hemoglobin A1c levels (up to 2.4% reduction at the 15 mg dose) and significant weight loss (average of 15% of body weight at 10 mg and 20.9% at 15 mg in the SURMOUNT-1 obesity trial)
When clinicians explain these biologic effects in simple terms, patients gain both understanding and confidence in their treatment journey
Consultation with a healthcare provider is essential to ensure safe and effective use
GLP-1 medications: Comparing side effects If youre exploring GLP-1 medications like semaglutide, tirzepatide, liraglutide, and dulaglutide, youll notice that while they share many similarities, each one can affect the body a bit differently